Table 3 Frequency and proportion of subjective posterior capsule opacification (PCO) at 3-years.

From: Randomized multicenter trial to assess posterior capsule opacification and glistenings in two hydrophobic acrylic intraocular lenses

PCO severity

Number of patients and percentage (%) implanted with Alcon IOL

Number of patients and percentage (%) implanted with HOYA IOL

Score 0 (none)

46 (68.66%)

50 (74.63%)

Score > 0–1 (none to minimal)

13 (19.40%)

14 (20.90%)

Score > 1–2 (minimal to mild)

6 (8.96%)

3 (4.48%)

Score > 2–3 (mild to moderate)

1 (1.49%)

0 (0.00%)

Score > 3–4 (moderate to severe)

1 (1.49%)

0 (0.00%)

  1. IOL intraocular lens.